Filing Flows › Tango Therapeutics (TNGX) › Next earnings date
Tango Therapeutics (TNGX) earnings on Nov 10, 2026: what to expect
Tango Therapeutics (TNGX) is expected to report earnings on Nov 10, 2026 (estimated), in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.35 (−$0.42 to −$0.30, 12 estimates), against $0.13 and $53.8M a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 65% chance of beating next time.
What to watch
Last quarter (Q3 2025) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS $0.14 on revenue of $55.2M, against the analysts' −$0.35.
The last report
Tango Therapeutics reported revenue of $53.8M for the third quarter 2025 (+364% Y/Y), net earnings $15.9M. How it makes money → · Every quarter →
Tango Therapeutics' latest quarter
Tango Therapeutics, Q3 2025: revenue $53.8M (+364% year over year), operating margin 26.2%, net earnings $15.9M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
Questions
When does TNGX report earnings?
Tango Therapeutics is expected to report on Nov 10, 2026 (estimated).
What are analysts expecting from Tango Therapeutics?
EPS of −$0.35 for the quarter.
Does Tango Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.